Publication type: | Article in scientific journal |
Type of review: | Peer review (publication) |
Title: | The WHO Mental Health Gap Action Programme for mental, neurological, and substance use conditions : the new and updated guideline recommendations |
Authors: | Brohan, Elaine Chowdhary, Neerja Dua, Tarun Barbui, Corrado Thornicroft, Graham Kestel, Dévora Ali, Amza Assanangkornchai, Sawitri Brodaty, Henry Carli, Vladimir El Chammay, Rabih Chang, Odille Collins, Pamela Y. Cuijpers, Pim Dowrick, Christopher Eaton, Julian Ferri, Cleusa P. Fortes, Sandra Hengartner, Michael P. Humayun, Asma Jette, Nathalie de Vries, Petrus J. Medina-Mora, Maria Elena Murthy, Pratima Nadera, Dinah Newton, Charles Njenga, Michael Omigbodun, Olayinka Rahimi-Movaghar, Afarin Rahman, Atif Fortunato dos Santos, Palmira Saxena, Shekhar Vijayakumar, Lakshmi Wang, Huali Wattanavitukul, Pichayanan Yewnetu, Enat Carswell, Ken Chatterjee, Sudipto Fatima, Batool Fleischmann, Alexandra Gray, Brandon Hanlon, Charlotte Hanna, Fahmy Krupchanka, Dzmitry Malik, Aiysha van Ommeren, Mark Poznyak, Vladimir Seeher, Katrin Servili, Chiara Weissbecker, Inka Baingana, Florence Alfonzo Bello, Luis Bruni, Andrea Jorge Dos Santos Ferreira Borges Bigot, Ana Carina Dorji, Chencho Vandendyck, Martin Lazeri, Ledia Monteiro, Maristela Goldnadel Rani, Manju Saeed, Khalid e Souza, Renato Oliveira Ameyan, Wole Baltag, Valentina Branca, Francesco Cappello, Bernadette Cometto, Giorgio Dalil, Suraya Gabrielli, Albis Huttner, Benedikt Jaramillo, Ernesto Khan, Taskeen King, Jonathan Krech, Ruediger Roebbel, Nathalie Tran, Nhan Sumi, Yuka Syed, Shams |
et. al: | No |
DOI: | 10.1016/S2215-0366(23)00370-X |
Published in: | The Lancet Psychiatry |
Volume(Issue): | 11 |
Issue: | 2 |
Page(s): | 155 |
Pages to: | 158 |
Issue Date: | Feb-2024 |
Publisher / Ed. Institution: | Elsevier |
ISSN: | 2215-0366 2215-0374 |
Language: | English |
Subject (DDC): | 362: Health and social services 616.89: Mental disorders, clinical psychology and psychiatry |
Abstract: | The WHO Mental Health Gap Action Programme (mhGAP) guideline update reflects 15 years of investment in reducing the treatment gap and scaling up care for people with mental, neurological, and substance use (MNS) conditions. It was produced by a guideline development group and steering group, with support from topic experts, using quantitative and qualitative evidence and a systematic review of use of mhGAP. 90 recommendations from the 2015 guideline update were validated and endorsed for use in their current format. These are joined by 30 revised recommendations and 18 new recommendations, including a new module on anxiety. Psychological interventions are emphasised as treatments and digitally delivered interventions feature across many modules, as well as updated recommendations for psychotropic medicines. Research gaps identified include the need for evidence from low-resource settings and on the views of people with lived experience of MNS conditions. The revised recommendations ensure that mhGAP continues to offer high-quality, timely, transparent, and evidence-based guidance to support non-specialist health workers in low-income and middle-income countries in providing care to individuals with MNS conditions. |
URI: | https://digitalcollection.zhaw.ch/handle/11475/29644 |
Fulltext version: | Published version |
License (according to publishing contract): | Licence according to publishing contract |
Departement: | Applied Psychology |
Organisational Unit: | Psychological Institute (PI) |
Appears in collections: | Publikationen Angewandte Psychologie |
Files in This Item:
There are no files associated with this item.
Show full item record
Brohan, E., Chowdhary, N., Dua, T., Barbui, C., Thornicroft, G., Kestel, D., Ali, A., Assanangkornchai, S., Brodaty, H., Carli, V., El Chammay, R., Chang, O., Collins, P. Y., Cuijpers, P., Dowrick, C., Eaton, J., Ferri, C. P., Fortes, S., Hengartner, M. P., et al. (2024). The WHO Mental Health Gap Action Programme for mental, neurological, and substance use conditions : the new and updated guideline recommendations. The Lancet Psychiatry, 11(2), 155–158. https://doi.org/10.1016/S2215-0366(23)00370-X
Brohan, E. et al. (2024) ‘The WHO Mental Health Gap Action Programme for mental, neurological, and substance use conditions : the new and updated guideline recommendations’, The Lancet Psychiatry, 11(2), pp. 155–158. Available at: https://doi.org/10.1016/S2215-0366(23)00370-X.
E. Brohan et al., “The WHO Mental Health Gap Action Programme for mental, neurological, and substance use conditions : the new and updated guideline recommendations,” The Lancet Psychiatry, vol. 11, no. 2, pp. 155–158, Feb. 2024, doi: 10.1016/S2215-0366(23)00370-X.
BROHAN, Elaine, Neerja CHOWDHARY, Tarun DUA, Corrado BARBUI, Graham THORNICROFT, Dévora KESTEL, Amza ALI, Sawitri ASSANANGKORNCHAI, Henry BRODATY, Vladimir CARLI, Rabih EL CHAMMAY, Odille CHANG, Pamela Y. COLLINS, Pim CUIJPERS, Christopher DOWRICK, Julian EATON, Cleusa P. FERRI, Sandra FORTES, Michael P. HENGARTNER, Asma HUMAYUN, Nathalie JETTE, Petrus J. DE VRIES, Maria Elena MEDINA-MORA, Pratima MURTHY, Dinah NADERA, Charles NEWTON, Michael NJENGA, Olayinka OMIGBODUN, Afarin RAHIMI-MOVAGHAR, Atif RAHMAN, Palmira FORTUNATO DOS SANTOS, Shekhar SAXENA, Lakshmi VIJAYAKUMAR, Huali WANG, Pichayanan WATTANAVITUKUL, Enat YEWNETU, Ken CARSWELL, Sudipto CHATTERJEE, Batool FATIMA, Alexandra FLEISCHMANN, Brandon GRAY, Charlotte HANLON, Fahmy HANNA, Dzmitry KRUPCHANKA, Aiysha MALIK, Mark VAN OMMEREN, Vladimir POZNYAK, Katrin SEEHER, Chiara SERVILI, Inka WEISSBECKER, Florence BAINGANA, Luis ALFONZO BELLO, Andrea BRUNI, Ana Carina JORGE DOS SANTOS FERREIRA BORGES BIGOT, Chencho DORJI, Martin VANDENDYCK, Ledia LAZERI, Maristela Goldnadel MONTEIRO, Manju RANI, Khalid SAEED, Renato Oliveira E SOUZA, Wole AMEYAN, Valentina BALTAG, Francesco BRANCA, Bernadette CAPPELLO, Giorgio COMETTO, Suraya DALIL, Albis GABRIELLI, Benedikt HUTTNER, Ernesto JARAMILLO, Taskeen KHAN, Jonathan KING, Ruediger KRECH, Nathalie ROEBBEL, Nhan TRAN, Yuka SUMI und Shams SYED, 2024. The WHO Mental Health Gap Action Programme for mental, neurological, and substance use conditions : the new and updated guideline recommendations. The Lancet Psychiatry. Februar 2024. Bd. 11, Nr. 2, S. 155–158. DOI 10.1016/S2215-0366(23)00370-X
Brohan, Elaine, Neerja Chowdhary, Tarun Dua, Corrado Barbui, Graham Thornicroft, Dévora Kestel, Amza Ali, et al. 2024. “The WHO Mental Health Gap Action Programme for Mental, Neurological, and Substance Use Conditions : The New and Updated Guideline Recommendations.” The Lancet Psychiatry 11 (2): 155–58. https://doi.org/10.1016/S2215-0366(23)00370-X.
Brohan, Elaine, et al. “The WHO Mental Health Gap Action Programme for Mental, Neurological, and Substance Use Conditions : The New and Updated Guideline Recommendations.” The Lancet Psychiatry, vol. 11, no. 2, Feb. 2024, pp. 155–58, https://doi.org/10.1016/S2215-0366(23)00370-X.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.